Thomas Wiggans
Président chez ANNEXON, INC.
Fortune : 105 900 $ au 30/04/2024
Provenance du réseau au premier degré de Thomas Wiggans
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers.
220
| Non-Profit Organization | Miscellaneous Commercial Services | 220 |
Kansas University Endowment Association
 Kansas University Endowment Association Miscellaneous Commercial ServicesCommercial Services Kansas University Endowment Association operates fundraising foundation for the University of Kansas, KU Endowment partners with donors in providing philanthropic support to build a greater KU. The company was founded in 1891 and is headquartered in Lawrence, KS.
115
| Non-Profit Organization | Miscellaneous Commercial Services | 115 |
University of Kansas
77
| College/University | Other Consumer Services | 77 |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA.
69
| Subsidiary | Pharmaceuticals: Major | 69 |
Southern Methodist University
 Southern Methodist University Other Consumer ServicesConsumer Services Southern Methodist University is a private university near the center of Dallas, SMU offers undergraduate, graduate, and professional programs through seven schools in the humanities and sciences, business, the performing, visual, and communication arts, engineering, education and human development, law, and theology.
68
| College/University | Other Consumer Services | 68 |
| Subsidiary | Pharmaceuticals: Major | 41 | |
Connetics Corp.
 Connetics Corp. BiotechnologyHealth Technology Connetics Corp. develops and commercializes dermatology products. The firm offers remedies for psoriasis in adults, eczema, seborrheic dermatitis, and acne. The company was founded in 1993 and is headquartered in Palo Alto, CA.
33
| Extinct | Biotechnology | 33 |
The Hoover Institution
23
| Private Company | 23 | |
| Public Company | Pharmaceuticals: Major | 21 | |
| Public Company | Financial Conglomerates | 17 | |
| Subsidiary | Biotechnology | 16 | |
| Subsidiary | Pharmaceuticals: Major | 16 | |
Somaxon Pharmaceuticals, Inc.
 Somaxon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Somaxon Pharmaceuticals, Inc. is a specialty pharmaceutical company. The company focuses on the in-licensing, development and commercialization of proprietary branded products and product candidates to treat important medical conditions where there is an unmet medical need and high-level of patient dissatisfaction, currently in the central nervous system therapeutic area. Its product, Silenor, is indicated for the treatment of insomnia characterized by difficulty with sleep maintenance. Somaxon Pharmaceuticals was founded in August 2003 and is headquartered in Solana Beach, CA.
16
| Extinct | Pharmaceuticals: Major | 16 |
| Subsidiary | Pharmaceuticals: Major | 14 | |
| Public Company | Biotechnology | 11 | |
Tercica, Inc.
 Tercica, Inc. Pharmaceuticals: MajorHealth Technology The Company's principal activity as a biopharmaceutical company is focused on the development and commercialization of products to improve endocrine health. Its first product, IncrelexTM (mecasermin {rDNA origin} injection), or recombinant human insulin-like growth factor-1 (rhIGF-1), is approved by the FDA for the treatment of severe Primary IGFD. The Company licensed the rights to develop, manufacture and commercialize Increlex from Genentech Inc.
7
| Extinct | Pharmaceuticals: Major | 7 |
Follica, Inc.
 Follica, Inc. Other Consumer ServicesConsumer Services Follica, Inc. develops therapies for hair follicle disorders. The firm provides an out-patient therapy coupled with an at-home system for the treatment of androgenetic alopecia (hair loss) and medical device development fields to develop and commercialize its product platform. The company was founded by Rox R. Anderson, George Cotsarelis, Vera Price, Daphne Zohar, David Steinberg, and Bernat Olle in 2006 and is headquartered in Boston, MA.
7
| Holding Company | Other Consumer Services | 7 |
Neothetics, Inc.
 Neothetics, Inc. Pharmaceuticals: MajorHealth Technology Neothetics, Inc. operates as a holding company, which provides clinical-stage specialty pharmaceutical and developing therapeutics for the aesthetic. It focuses on localized fat reduction and body contouring. The company products include LIPO-202, is an injectable formulation of the long-acting ß2-adrenergic receptor agonist, salmeterol xinafoate. Neothetics was founded by John D. Dobak in February 2007 and is headquartered in San Diego, CA.
7
| Extinct | Pharmaceuticals: Major | 7 |
FORMA Therapeutics, Inc.
 FORMA Therapeutics, Inc. BiotechnologyHealth Technology FORMA Therapeutics, Inc. discovers and develops medicines for cancer and other genetically driven diseases. Its drug discovery engine deploys screening and structure-based approaches across broad families of targets involved in tumor metabolism, epigenetics, protein homeostasis, and protein-protein interactions. The company was founded by Steven Tregay, Nikolai Kley, Stuart L. Schreiber, Todd R. Golub, Michael Foley and Alexis Borisy in 2008 and is headquartered in Watertown, MA.
7
| Subsidiary | Biotechnology | 7 |
Peplin, Inc.
 Peplin, Inc. Pharmaceuticals: MajorHealth Technology Peplin, Inc. develops drugs and pharmaceutical products. The company was founded by James Harrison Aylward in 1998 and is headquartered in Emeryville, CA.
6
| Subsidiary | Pharmaceuticals: Major | 6 |
The Biotechnology Institute
 The Biotechnology Institute Miscellaneous Commercial ServicesCommercial Services The Biotechnology Institute is a non-profit organization, which engages in designing and managing programs about biotechnology research. Its programs include BioGENEius Challenges, leadership awards, and Adopt-A-School. The company was founded in 1998 and is headquartered in Washington, DC.
6
| Non-Profit Organization | Miscellaneous Commercial Services | 6 |
Annexon Biosciences, Inc.
6
| Private Company | 6 | |
Ares-Serono Group
 Ares-Serono Group Pharmaceuticals: MajorHealth Technology Ares-Serono Group is a Swiss pharmaceutical company that manufactures and wholesales pharmaceutical products. The private company is based in Geneva, Switzerland. and has subsidiaries in Ecuador.
6
| Private Company | Pharmaceuticals: Major | 6 |
Excaliard Pharmaceuticals, Inc.
 Excaliard Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Excaliard Pharmaceuticals, Inc. manufactures, develops therapeutics for the treatment of scarring and fibrotic disorders. The company was founded by John Gordon Foulkes and Nicholas M. Dean in 2006 and is headquartered in New York, NY.
3
| Subsidiary | Pharmaceuticals: Major | 3 |
CytoTherapuetics, Inc.
2
| Extinct | Financial Conglomerates | 2 |
Kansas Association of Defense Counsel
2
| Non-Profit Organization | 2 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Thomas Wiggans via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | General Counsel Chief Operating Officer Corporate Officer/Principal Corporate Officer/Principal General Counsel | |
Biogen MA, Inc.
 Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Biotechnology | President Corporate Officer/Principal | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Sales & Marketing | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Chief Operating Officer Corporate Officer/Principal General Counsel Corporate Officer/Principal Corporate Officer/Principal General Counsel Corporate Officer/Principal | |
| GILEAD SCIENCES, INC. | Biotechnology | Director/Board Member Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Chief Operating Officer Corporate Officer/Principal | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal | |
| BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Chairman Corporate Officer/Principal | |
Allos Therapeutics, Inc.
 Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Allos Therapeutics, Inc. is a biopharmaceutical company committed to the development and commercialization of innovative anti-cancer therapeutics. It focuses on the development and commercialization FOLOTYN a pralatrexate injection. FOLOTYN is a folate analogue metabolic inhibitor designed to accumulate preferentially in cancer cells. It targets the inhibition of dihydrofolate reductase, or DHFR, an enzyme critical in the folate pathway, thereby interfering with DNA and RNA synthesis and triggering cancer cell death. Allos Therapeutics is also developing FOLOTYN in other hematologic malignancies and solid tumors. The company was founded on September 1, 1992 and is headquartered in Westminster, CO. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member | |
| CEPHEID | Medical Specialties | Director/Board Member Chief Executive Officer | |
| SEAGEN INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal General Counsel Director/Board Member | |
| HUMANIGEN, INC. | Biotechnology | Chief Executive Officer Chairman Chairman | |
| PORTOLA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member Corporate Officer/Principal | |
| ULTRAGENYX PHARMACEUTICAL INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
MPM BioImpact, Inc
 MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Corporate Officer/Principal Corporate Officer/Principal | |
| The Trustees of Columbia University in The City of New York | College/University | Graduate Degree Undergraduate Degree | |
| Stanford University | College/University | Masters Business Admin Corporate Officer/Principal | |
| AFFYMAX, INC. | Biotechnology | Director of Finance/CFO Chairman Director/Board Member | |
| MACROGENICS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| ALNYLAM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Executive Officer | |
| INNOVIVA, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
MRIGlobal
 MRIGlobal Miscellaneous Commercial ServicesCommercial Services MRIGlobal operates research and development organizations. The firm's programs include environmental research, health, pharmaceutical product development, agriculture & food safety, and national security, defense & energy. The company was founded in 1944 and headquartered in Kansas City, MO. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| Massachusetts Institute of Technology | College/University | Graduate Degree Undergraduate Degree | |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses | College/University | Undergraduate Degree Director/Board Member Graduate Degree | |
| The University of Texas at Austin | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree | |
| Indiana University | College/University | Graduate Degree Masters Business Admin | |
| New York University | College/University | Corporate Officer/Principal Graduate Degree | |
| Princeton University | College/University | Undergraduate Degree Undergraduate Degree | |
| The University of Colorado | College/University | Corporate Officer/Principal Graduate Degree | |
Council on Foreign Relations, Inc.
 Council on Foreign Relations, Inc. Investment Trusts/Mutual FundsMiscellaneous Council on Foreign Relations, Inc. provides and disseminates ideas on foreign policies to individuals, corporate members, journalists and policy makers. It operates a forum for government officials, students and other interested parties to study and discuss world issues and impact on American foreign policies. The company publishes Foreign Affairs, a magazine that comes out six times a year, along with books and studies by its own scholars. Council on Foreign Relations was founded in 1921 and is headquartered in New York City, NY. | Investment Trusts/Mutual Funds | Corporate Officer/Principal Director/Board Member Corporate Officer/Principal | |
Stanford Health Care
 Stanford Health Care Hospital/Nursing ManagementHealth Services Stanford Health Care provides healthcare services. It services includes cardiac care, cancer treatment, neurosciences, surgery and organ transplants. The company was founded in 1956 and is headquartered in Stanford, CA. | Hospital/Nursing Management | Director/Board Member Chief Tech/Sci/R&D Officer | |
National Academy of Medicine (United States)
 National Academy of Medicine (United States) Miscellaneous Commercial ServicesCommercial Services The National Academy of Medicine (United States) is based in Washington and is focused on improving the health and well-being of individuals through various initiatives. These initiatives include the clinician well-being collaborative, which aims to accelerate the implementation of a national plan for health workforce well-being, and the development of a code of conduct for the use of artificial intelligence in health care. The organization also provides resources to support meaningful community engagement in health and health care programs and policies. Recently, the National Academy of Medicine announced the appointment of Mandy Cohen, a member of the organization, as the director of the Centers for Disease Control and Prevention. Additionally, the organization has released a publication celebrating 50 years of progress in biomedical science, health, and health care. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
American Skin Association, Inc.
 American Skin Association, Inc. Miscellaneous Commercial ServicesCommercial Services American Skin Association, Inc. engages in the development and research, education, prevention and treatment of skin disorders and cancers. It offers efforts to defeat melanoma, skin cancer and disease. The company was founded by George W. Hambrick on January 09, 1987 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
American Dermatological Association, Inc.
 American Dermatological Association, Inc. Miscellaneous Commercial ServicesCommercial Services American Dermatological Association, Inc. recognizes, discusses and develops solutions for problems in the area of dermatologic health care, research and education. The company was founded in 1876 and is headquartered in Fort Lauderdale, FL. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
| Harvard Medical School | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| SYROS PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Chairman | |
Jasper Tx Corp.
 Jasper Tx Corp. BiotechnologyHealth Technology Jasper Tx Corp. operates as a biotechnology company. It engages in the clinical development of novel therapies. The company was founded by Susan S. Prohaska and Judith Shizuru and is headquartered in Mountain View, CA. | Biotechnology | Director/Board Member Director/Board Member Founder | |
| Stanford University School of Medicine | College/University | Doctorate Degree Corporate Officer/Principal Doctorate Degree | |
| CRISPR THERAPEUTICS AG | Biotechnology | Director/Board Member Director/Board Member Chairman | |
| ASSEMBLY BIOSCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member Chairman Founder | |
| DECIBEL THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer Chairman | |
The Sync Project, Inc.
 The Sync Project, Inc. Packaged SoftwareTechnology Services The Sync Project, Inc. develops a platform to scientifically measure and harness music to improve health. The company was founded by Marko Ahtisaari, Ketki Karanam and Yadid Ayzenberg and is headquartered in Boston, MA. | Packaged Software | Director/Board Member Director/Board Member | |
| Stanford Graduate School of Business | College/University | Chairman Masters Business Admin | |
MorphImmune, Inc.
 MorphImmune, Inc. BiotechnologyHealth Technology MorphImmune, Inc. is a biotechnology company that specializes in developing targeted oncology therapeutics. MorphImmune is based in West Lafayette, IN and has been led by CEO Clay B. Siegall since 2023. The company's proprietary targeted effector platform delivers payloads to diseased cells, reducing toxicity and increasing efficacy of known effector molecules. The company was founded on the research of Philip S. Low, Ph.D., the Presidential Scholar for Drug Discovery and Ralph C. Corley Distinguished Professor of Chemistry at Purdue University. | Biotechnology | Director/Board Member Chief Executive Officer | |
| GLOBAL BLOOD THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
Tizona Therapeutics, Inc.
 Tizona Therapeutics, Inc. BiotechnologyHealth Technology Tizona Therapeutics, Inc. is an immunology company harnessing the power of the immune system to develop treatments for cancer and autoimmune diseases. Its products include anti-ccr4 antibody for the treatment of cancer, il-35 antagonists for the treatment of cancer, and il-35 agonists for the treatment of autoimmune diseases. The company was founded by Charles G. Drake, Vijay K. Kuchroo, Drew M. Pardoll, Dario Vignali, Wayne A. Marasco and Jedd D. Wolchok and is headquartered in South San Francisco, CA. | Biotechnology | Chief Executive Officer Director/Board Member |
Statistiques
Internationale
| Etats-Unis | 48 |
| Mexique | 2 |
| Suisse | 2 |
Sectorielle
| Health Technology | 30 |
| Consumer Services | 12 |
| Commercial Services | 5 |
| Finance | 3 |
| Miscellaneous | 2 |
Opérationnelle
| Director/Board Member | 629 |
| Corporate Officer/Principal | 204 |
| Independent Dir/Board Member | 185 |
| Chairman | 149 |
| Chief Executive Officer | 102 |
Relations les plus connectées
| Insiders | |
|---|---|
| John Maraganore | 38 |
| Muneer Satter | 35 |
| Eugene Bauer | 34 |
| Kurt von Emster | 34 |
| Peter Kolchinsky | 32 |
| William Young | 32 |
| William Ringo | 32 |
| Ted Love | 31 |
| N. Coles | 30 |
| Steven Holtzman | 28 |
| David Pyott | 27 |
| James Sapirstein | 26 |
| Pablo Cagnoni | 24 |
| Wayne Frederick | 24 |
| Daphne Zohar | 22 |
- Bourse
- Insiders
- Thomas Wiggans
- Connexions Sociétés